|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:BNC2-UHRF2 (FusionGDB2 ID:10039) |
Fusion Gene Summary for BNC2-UHRF2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: BNC2-UHRF2 | Fusion gene ID: 10039 | Hgene | Tgene | Gene symbol | BNC2 | UHRF2 | Gene ID | 54796 | 115426 |
Gene name | basonuclin 2 | ubiquitin like with PHD and ring finger domains 2 | |
Synonyms | BSN2|LUTO | NIRF|RNF107|TDRD23|URF2 | |
Cytomap | 9p22.3-p22.2 | 9p24.1 | |
Type of gene | protein-coding | protein-coding | |
Description | zinc finger protein basonuclin-2 | E3 ubiquitin-protein ligase UHRF2Np95-like ring finger proteinRING finger protein 107RING-type E3 ubiquitin transferase UHRF2np95/ICBP90-like RING finger proteinnuclear protein 97nuclear zinc finger protein NP97ubiquitin-like PHD and RING finger do | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000380672, ENST00000380667, ENST00000545497, ENST00000380666, ENST00000471301, | ENST00000276893, ENST00000381373, ENST00000485617, | |
Fusion gene scores | * DoF score | 12 X 16 X 6=1152 | 14 X 11 X 8=1232 |
# samples | 16 | 16 | |
** MAII score | log2(16/1152*10)=-2.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(16/1232*10)=-2.94485844580754 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: BNC2 [Title/Abstract] AND UHRF2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | BNC2(16870644)-UHRF2(6420912), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | UHRF2 | GO:0016567 | protein ubiquitination | 14741369 |
Tgene | UHRF2 | GO:0051865 | protein autoubiquitination | 14741369 |
Tgene | UHRF2 | GO:0071158 | positive regulation of cell cycle arrest | 15178429 |
Fusion gene breakpoints across BNC2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across UHRF2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | SARC | TCGA-DX-AB2E-01A | BNC2 | chr9 | 16870644 | - | UHRF2 | chr9 | 6420912 | + |
Top |
Fusion Gene ORF analysis for BNC2-UHRF2 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000380672 | ENST00000276893 | BNC2 | chr9 | 16870644 | - | UHRF2 | chr9 | 6420912 | + |
In-frame | ENST00000380672 | ENST00000381373 | BNC2 | chr9 | 16870644 | - | UHRF2 | chr9 | 6420912 | + |
5CDS-intron | ENST00000380672 | ENST00000485617 | BNC2 | chr9 | 16870644 | - | UHRF2 | chr9 | 6420912 | + |
In-frame | ENST00000380667 | ENST00000276893 | BNC2 | chr9 | 16870644 | - | UHRF2 | chr9 | 6420912 | + |
In-frame | ENST00000380667 | ENST00000381373 | BNC2 | chr9 | 16870644 | - | UHRF2 | chr9 | 6420912 | + |
5CDS-intron | ENST00000380667 | ENST00000485617 | BNC2 | chr9 | 16870644 | - | UHRF2 | chr9 | 6420912 | + |
intron-3CDS | ENST00000545497 | ENST00000276893 | BNC2 | chr9 | 16870644 | - | UHRF2 | chr9 | 6420912 | + |
intron-3CDS | ENST00000545497 | ENST00000381373 | BNC2 | chr9 | 16870644 | - | UHRF2 | chr9 | 6420912 | + |
intron-intron | ENST00000545497 | ENST00000485617 | BNC2 | chr9 | 16870644 | - | UHRF2 | chr9 | 6420912 | + |
In-frame | ENST00000380666 | ENST00000276893 | BNC2 | chr9 | 16870644 | - | UHRF2 | chr9 | 6420912 | + |
In-frame | ENST00000380666 | ENST00000381373 | BNC2 | chr9 | 16870644 | - | UHRF2 | chr9 | 6420912 | + |
5CDS-intron | ENST00000380666 | ENST00000485617 | BNC2 | chr9 | 16870644 | - | UHRF2 | chr9 | 6420912 | + |
intron-3CDS | ENST00000471301 | ENST00000276893 | BNC2 | chr9 | 16870644 | - | UHRF2 | chr9 | 6420912 | + |
intron-3CDS | ENST00000471301 | ENST00000381373 | BNC2 | chr9 | 16870644 | - | UHRF2 | chr9 | 6420912 | + |
intron-intron | ENST00000471301 | ENST00000485617 | BNC2 | chr9 | 16870644 | - | UHRF2 | chr9 | 6420912 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000380672 | BNC2 | chr9 | 16870644 | - | ENST00000276893 | UHRF2 | chr9 | 6420912 | + | 3192 | 61 | 58 | 2316 | 752 |
ENST00000380672 | BNC2 | chr9 | 16870644 | - | ENST00000381373 | UHRF2 | chr9 | 6420912 | + | 637 | 61 | 58 | 318 | 86 |
ENST00000380667 | BNC2 | chr9 | 16870644 | - | ENST00000276893 | UHRF2 | chr9 | 6420912 | + | 3217 | 86 | 14 | 2341 | 775 |
ENST00000380667 | BNC2 | chr9 | 16870644 | - | ENST00000381373 | UHRF2 | chr9 | 6420912 | + | 662 | 86 | 14 | 343 | 109 |
ENST00000380666 | BNC2 | chr9 | 16870644 | - | ENST00000276893 | UHRF2 | chr9 | 6420912 | + | 3274 | 143 | 71 | 2398 | 775 |
ENST00000380666 | BNC2 | chr9 | 16870644 | - | ENST00000381373 | UHRF2 | chr9 | 6420912 | + | 719 | 143 | 71 | 400 | 109 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000380672 | ENST00000276893 | BNC2 | chr9 | 16870644 | - | UHRF2 | chr9 | 6420912 | + | 0.00010758 | 0.99989235 |
ENST00000380672 | ENST00000381373 | BNC2 | chr9 | 16870644 | - | UHRF2 | chr9 | 6420912 | + | 0.29925567 | 0.7007444 |
ENST00000380667 | ENST00000276893 | BNC2 | chr9 | 16870644 | - | UHRF2 | chr9 | 6420912 | + | 0.000109578 | 0.99989045 |
ENST00000380667 | ENST00000381373 | BNC2 | chr9 | 16870644 | - | UHRF2 | chr9 | 6420912 | + | 0.28980055 | 0.7101994 |
ENST00000380666 | ENST00000276893 | BNC2 | chr9 | 16870644 | - | UHRF2 | chr9 | 6420912 | + | 0.000112517 | 0.99988747 |
ENST00000380666 | ENST00000381373 | BNC2 | chr9 | 16870644 | - | UHRF2 | chr9 | 6420912 | + | 0.18227217 | 0.81772786 |
Top |
Fusion Genomic Features for BNC2-UHRF2 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
BNC2 | chr9 | 16870643 | - | UHRF2 | chr9 | 6420911 | + | 8.55E-05 | 0.9999145 |
BNC2 | chr9 | 16870643 | - | UHRF2 | chr9 | 6420911 | + | 8.55E-05 | 0.9999145 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for BNC2-UHRF2 |
Go to FGviewer for the breakpoints of chr9:16870644-chr9:6420912 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | UHRF2 | chr9:16870644 | chr9:6420912 | ENST00000276893 | 0 | 16 | 448_612 | 51.0 | 803.0 | Domain | YDG | |
Tgene | UHRF2 | chr9:16870644 | chr9:6420912 | ENST00000276893 | 0 | 16 | 344_395 | 51.0 | 803.0 | Zinc finger | PHD-type | |
Tgene | UHRF2 | chr9:16870644 | chr9:6420912 | ENST00000276893 | 0 | 16 | 733_772 | 51.0 | 803.0 | Zinc finger | RING-type |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | BNC2 | chr9:16870644 | chr9:6420912 | ENST00000380666 | - | 1 | 7 | 534_614 | 1.0 | 904.0 | Compositional bias | Pro-rich |
Hgene | BNC2 | chr9:16870644 | chr9:6420912 | ENST00000380672 | - | 1 | 7 | 534_614 | 1.0 | 1100.0 | Compositional bias | Pro-rich |
Hgene | BNC2 | chr9:16870644 | chr9:6420912 | ENST00000380666 | - | 1 | 7 | 1035_1058 | 1.0 | 904.0 | Zinc finger | C2H2-type 3 |
Hgene | BNC2 | chr9:16870644 | chr9:6420912 | ENST00000380666 | - | 1 | 7 | 1063_1090 | 1.0 | 904.0 | Zinc finger | C2H2-type 4 |
Hgene | BNC2 | chr9:16870644 | chr9:6420912 | ENST00000380666 | - | 1 | 7 | 441_464 | 1.0 | 904.0 | Zinc finger | C2H2-type 1 |
Hgene | BNC2 | chr9:16870644 | chr9:6420912 | ENST00000380666 | - | 1 | 7 | 833_856 | 1.0 | 904.0 | Zinc finger | C2H2-type 2 |
Hgene | BNC2 | chr9:16870644 | chr9:6420912 | ENST00000380672 | - | 1 | 7 | 1035_1058 | 1.0 | 1100.0 | Zinc finger | C2H2-type 3 |
Hgene | BNC2 | chr9:16870644 | chr9:6420912 | ENST00000380672 | - | 1 | 7 | 1063_1090 | 1.0 | 1100.0 | Zinc finger | C2H2-type 4 |
Hgene | BNC2 | chr9:16870644 | chr9:6420912 | ENST00000380672 | - | 1 | 7 | 441_464 | 1.0 | 1100.0 | Zinc finger | C2H2-type 1 |
Hgene | BNC2 | chr9:16870644 | chr9:6420912 | ENST00000380672 | - | 1 | 7 | 833_856 | 1.0 | 1100.0 | Zinc finger | C2H2-type 2 |
Tgene | UHRF2 | chr9:16870644 | chr9:6420912 | ENST00000276893 | 0 | 16 | 1_78 | 51.0 | 803.0 | Domain | Ubiquitin-like |
Top |
Fusion Gene Sequence for BNC2-UHRF2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000380672_ENST00000276893_TCGA-DX-AB2E-01A_BNC2_chr9_16870644_-_UHRF2_chr9_6420912_length(transcript)=3192nt_BP=61nt GCGGCCGCTAAGAGGAGACCAAGAGGCGGGGGCTGCACTTGACAACCAGCATGCCGAGATGTTGGAAAATGGATATACCTTATTTGATTA TGATGTTGGACTGAATGATATAATTCAGCTGCTAGTTCGCCCAGACCCTGATCATCTTCCTGGCACATCTACACAGATTGAGGCTAAACC CTGTTCTAATAGTCCACCTAAAGTAAAGAAAGCTCCGAGGGTAGGACCTTCCAATCAGCCATCTACATCAGCTCGTGCCCGTCTTATTGA TCCTGGCTTTGGAATATATAAGGTAAATGAATTGGTGGATGCCAGAGATGTCGGCCTTGGTGCTTGGTTTGAAGCACACATACATAGTGT TACTAGAGCTTCTGATGGACAGTCACGTGGCAAAACTCCACTGAAGAATGGCAGTTCTTGTAAAAGGACTAATGGAAATATAAAGCATAA ATCCAAAGAGAACACAAATAAATTGGACAGTGTACCCTCTACGTCTAATTCAGACTGTGTTGCTGCTGATGAAGACGTTATTTACCATAT CCAGTATGATGAATACCCAGAAAGCGGTACTCTAGAAATGAATGTCAAGGATCTTAGACCACGAGCTAGAACCATTTTGAAATGGAATGA ACTAAATGTTGGTGATGTGGTAATGGTTAATTATAATGTAGAAAGTCCTGGACAAAGAGGATTCTGGTTTGATGCAGAAATTACCACATT GAAGACAATCTCAAGGACCAAAAAAGAACTTCGTGTGAAAATTTTCCTGGGGGGTTCTGAAGGAACATTAAATGACTGCAAGATAATATC TGTAGATGAAATCTTCAAGATTGAGAGACCTGGAGCCCATCCCCTTTCATTTGCAGATGGAAAGTTTTTAAGGCGAAATGACCCTGAATG TGACCTGTGTGGTGGAGACCCAGAAAAGAAATGTCATTCTTGCTCCTGTCGTGTATGTGGTGGGAAACATGAACCCAACATGCAGCTTCT GTGTGATGAATGTAATGTGGCTTATCATATTTACTGTCTGAATCCACCTTTGGATAAAGTCCCAGAAGAGGAATACTGGTATTGTCCTTC TTGTAAAACTGATTCCAGTGAAGTTGTAAAGGCTGGTGAAAGACTCAAGATGAGTAAAAAGAAAGCAAAGATGCCGTCAGCTAGTACTGA AAGCCGAAGAGACTGGGGCAGGGGAATGGCTTGTGTTGGTCGTACGAGAGAATGTACTATTGTCCCTTCTAATCATTATGGACCCATTCC TGGTATTCCTGTTGGATCAACTTGGAGATTTAGAGTTCAGGTGAGCGAAGCAGGTGTTCACAGACCCCATGTTGGTGGAATTCATGGTCG AAGTAATGATGGGGCTTATTCTCTTGTACTGGCTGGTGGATTTGCGGATGAAGTCGACCGAGGTGATGAGTTCACATACACTGGAAGCGG TGGTAAAAATCTTGCTGGTAACAAAAGAATTGGTGCACCTTCAGCTGATCAAACATTAACAAACATGAACAGGGCATTGGCCCTAAACTG TGATGCTCCATTGGATGATAAAATTGGAGCAGAGTCTCGGAATTGGAGAGCTGGTAAGCCAGTCAGAGTGATACGCAGTTTTAAAGGGAG GAAGATCAGCAAATATGCTCCTGAAGAAGGCAACAGATATGATGGCATTTATAAGGTGGTGAAATACTGGCCAGAGATTTCATCAAGCCA TGGATTCTTGGTTTGGCGCTATCTTTTAAGAAGAGATGATGTTGAACCTGCTCCTTGGACCTCTGAAGGAATAGAACGGTCAAGGAGATT ATGTCTACGTTTACAGTATCCAGCAGGTTACCCTTCAGATAAAGAAGGGAAGAAGCCTAAAGGACAGTCAAAGAAGCAGCCCAGTGGAAC CACAAAAAGGCCAATTTCAGATGATGACTGTCCAAGTGCCTCCAAAGTGTACAAAGCATCAGATTCAGCAGAAGCAATTGAGGCTTTTCA ACTAACTCCTCAACAGCAACATCTCATCAGAGAAGATTGTCAAAACCAGAAGCTGTGGGATGAAGTGCTTTCACATCTTGTGGAAGGACC AAATTTTCTGAAAAAATTGGAACAATCTTTTATGTGCGTTTGCTGTCAGGAGCTAGTTTACCAGCCTGTGACAACTGAGTGCTTCCACAA TGTCTGTAAAGATTGCCTACAGCGCTCCTTTAAGGCACAGGTTTTCTCCTGCCCTGCTTGCCGGCATGATCTTGGCCAGAATTACATCAT GATTCCCAATGAGATTCTGCAGACTCTACTTGACCTTTTCTTCCCTGGCTACAGCAAAGGACGATGATCTGCCTGCTTTCACTGTGTTGT TCATGGTGGCTTTTTGGACAATAAAGAATCTAAAATGGGTGGGGAGGGTGGAAGAAATGGTGGACTGTATCTCTCACGTTCTGAAGCAGC TAATCCTCTTTCCCACATAGCCATCATCTTGTGTGTGTAGTAAGAGGCCCATTTCTCAACTGTCTTTTAAATATCTAAAGGTAGTTCCTG TAACAACTAGTTTTAATGAGTAAAAAGTCAAAGCCTCAGCTCTAGTTGATATCCAAGTTATGATTTATTTTGCAACTACCTCAGGACAGA AAAGATTTATGGGGATTTTAAAAATCATTGAATAACTAGTTAAATGAAATTTTAGCTACACACTGCCTCCCAAATATTAGTTGTGCCTGG TTCTTGTAATTTGATTTTACAGAAAAGGAAATGACACTTGAGATCCTTGGAATGAACACAGCTTCTAAAGTGTGCATATACTTTTTTAAC GTCTCTTCTTCCATTACAATGTGTGTTTTGCAAGGACAGGTTCATTTTTTTTAGCCCACTTTGTGAACTCCATTGTGCTTTTTTCTGGTG TTTTATGCAAGTTGACTACTAATGACTAATGAGAACAATAATGAATGCATTGTTGCTGCATTAGTGTAATGTGGTGTGGTTTTGCACTTA AAAGAGGTATTCATATGCTCTAGTTGTAAATGTTCATGAAAATCCACTTCTCTACTAGTCGAACTGCTTTTAGTGTCTCACCAGTGGTTT TACATCTGCAGAGTTTTGAGGGCTGTGCTGACCTTTGAGAGGATTTGAAATTGCTTCATATTGTGATCCTAAATTTTATATTCACTATAT >In-frame_ENST00000380672_ENST00000276893_TCGA-DX-AB2E-01A_BNC2_chr9_16870644_-_UHRF2_chr9_6420912_length(amino acids)=752AA_start in transcript=58_stop in transcript=2316 MLENGYTLFDYDVGLNDIIQLLVRPDPDHLPGTSTQIEAKPCSNSPPKVKKAPRVGPSNQPSTSARARLIDPGFGIYKVNELVDARDVGL GAWFEAHIHSVTRASDGQSRGKTPLKNGSSCKRTNGNIKHKSKENTNKLDSVPSTSNSDCVAADEDVIYHIQYDEYPESGTLEMNVKDLR PRARTILKWNELNVGDVVMVNYNVESPGQRGFWFDAEITTLKTISRTKKELRVKIFLGGSEGTLNDCKIISVDEIFKIERPGAHPLSFAD GKFLRRNDPECDLCGGDPEKKCHSCSCRVCGGKHEPNMQLLCDECNVAYHIYCLNPPLDKVPEEEYWYCPSCKTDSSEVVKAGERLKMSK KKAKMPSASTESRRDWGRGMACVGRTRECTIVPSNHYGPIPGIPVGSTWRFRVQVSEAGVHRPHVGGIHGRSNDGAYSLVLAGGFADEVD RGDEFTYTGSGGKNLAGNKRIGAPSADQTLTNMNRALALNCDAPLDDKIGAESRNWRAGKPVRVIRSFKGRKISKYAPEEGNRYDGIYKV VKYWPEISSSHGFLVWRYLLRRDDVEPAPWTSEGIERSRRLCLRLQYPAGYPSDKEGKKPKGQSKKQPSGTTKRPISDDDCPSASKVYKA SDSAEAIEAFQLTPQQQHLIREDCQNQKLWDEVLSHLVEGPNFLKKLEQSFMCVCCQELVYQPVTTECFHNVCKDCLQRSFKAQVFSCPA -------------------------------------------------------------- >In-frame_ENST00000380672_ENST00000381373_TCGA-DX-AB2E-01A_BNC2_chr9_16870644_-_UHRF2_chr9_6420912_length(transcript)=637nt_BP=61nt GCGGCCGCTAAGAGGAGACCAAGAGGCGGGGGCTGCACTTGACAACCAGCATGCCGAGATGTTGGAAAATGGATATACCTTATTTGATTA TGATGTTGGACTGAATGATATAATTCAGCTGCTAGTTCGCCCAGACCCTGATCATCTTCCTGGCACATCTACACAGATTGAGGCTAAACC CTGTTCTAATAGTCCACCTAAAGTAAAGAAAGCTCCGAGGGTAGGACCTTCCAATCAGCCATCTACATCAGCTCGTGCCCGTCTTATTGA TCCTGGCTTTGGAATATATAAGGGTCTGGCTCTGTCACCCAGGCTGTAGTGCAGTGACGTGAACACGGCTCGCTGTAGCCTTGACCTGCT GGGGTCAAGTGATCTTCCTGCTCGGCCTCCCAAAGTGCTGGGATACAGGCGTGAGCCACCATGCCCGGCTAACTTAGATCTTTGATATCT TGATTAGTTCTTTCTTTACATATTTAATATTTTGCTTTATTTCTGGTAGCTTTGTTTTTGATGCAATTATTATATATGGTTATCTTCTAA AATAGTAATCTGTTTGCTGATATAGAGAAATGAAATTGATTTATTTGGCTTTTGTAACCAGCAACCTTTTCAAATCTAATAAATTGTGTA >In-frame_ENST00000380672_ENST00000381373_TCGA-DX-AB2E-01A_BNC2_chr9_16870644_-_UHRF2_chr9_6420912_length(amino acids)=86AA_start in transcript=58_stop in transcript=318 -------------------------------------------------------------- >In-frame_ENST00000380667_ENST00000276893_TCGA-DX-AB2E-01A_BNC2_chr9_16870644_-_UHRF2_chr9_6420912_length(transcript)=3217nt_BP=86nt CGGCGGCCGAGGGGCTGGTCCAGGCGCGGCCGCTAAGAGGAGACCAAGAGGCGGGGGCTGCACTTGACAACCAGCATGCCGAGATGTTGG AAAATGGATATACCTTATTTGATTATGATGTTGGACTGAATGATATAATTCAGCTGCTAGTTCGCCCAGACCCTGATCATCTTCCTGGCA CATCTACACAGATTGAGGCTAAACCCTGTTCTAATAGTCCACCTAAAGTAAAGAAAGCTCCGAGGGTAGGACCTTCCAATCAGCCATCTA CATCAGCTCGTGCCCGTCTTATTGATCCTGGCTTTGGAATATATAAGGTAAATGAATTGGTGGATGCCAGAGATGTCGGCCTTGGTGCTT GGTTTGAAGCACACATACATAGTGTTACTAGAGCTTCTGATGGACAGTCACGTGGCAAAACTCCACTGAAGAATGGCAGTTCTTGTAAAA GGACTAATGGAAATATAAAGCATAAATCCAAAGAGAACACAAATAAATTGGACAGTGTACCCTCTACGTCTAATTCAGACTGTGTTGCTG CTGATGAAGACGTTATTTACCATATCCAGTATGATGAATACCCAGAAAGCGGTACTCTAGAAATGAATGTCAAGGATCTTAGACCACGAG CTAGAACCATTTTGAAATGGAATGAACTAAATGTTGGTGATGTGGTAATGGTTAATTATAATGTAGAAAGTCCTGGACAAAGAGGATTCT GGTTTGATGCAGAAATTACCACATTGAAGACAATCTCAAGGACCAAAAAAGAACTTCGTGTGAAAATTTTCCTGGGGGGTTCTGAAGGAA CATTAAATGACTGCAAGATAATATCTGTAGATGAAATCTTCAAGATTGAGAGACCTGGAGCCCATCCCCTTTCATTTGCAGATGGAAAGT TTTTAAGGCGAAATGACCCTGAATGTGACCTGTGTGGTGGAGACCCAGAAAAGAAATGTCATTCTTGCTCCTGTCGTGTATGTGGTGGGA AACATGAACCCAACATGCAGCTTCTGTGTGATGAATGTAATGTGGCTTATCATATTTACTGTCTGAATCCACCTTTGGATAAAGTCCCAG AAGAGGAATACTGGTATTGTCCTTCTTGTAAAACTGATTCCAGTGAAGTTGTAAAGGCTGGTGAAAGACTCAAGATGAGTAAAAAGAAAG CAAAGATGCCGTCAGCTAGTACTGAAAGCCGAAGAGACTGGGGCAGGGGAATGGCTTGTGTTGGTCGTACGAGAGAATGTACTATTGTCC CTTCTAATCATTATGGACCCATTCCTGGTATTCCTGTTGGATCAACTTGGAGATTTAGAGTTCAGGTGAGCGAAGCAGGTGTTCACAGAC CCCATGTTGGTGGAATTCATGGTCGAAGTAATGATGGGGCTTATTCTCTTGTACTGGCTGGTGGATTTGCGGATGAAGTCGACCGAGGTG ATGAGTTCACATACACTGGAAGCGGTGGTAAAAATCTTGCTGGTAACAAAAGAATTGGTGCACCTTCAGCTGATCAAACATTAACAAACA TGAACAGGGCATTGGCCCTAAACTGTGATGCTCCATTGGATGATAAAATTGGAGCAGAGTCTCGGAATTGGAGAGCTGGTAAGCCAGTCA GAGTGATACGCAGTTTTAAAGGGAGGAAGATCAGCAAATATGCTCCTGAAGAAGGCAACAGATATGATGGCATTTATAAGGTGGTGAAAT ACTGGCCAGAGATTTCATCAAGCCATGGATTCTTGGTTTGGCGCTATCTTTTAAGAAGAGATGATGTTGAACCTGCTCCTTGGACCTCTG AAGGAATAGAACGGTCAAGGAGATTATGTCTACGTTTACAGTATCCAGCAGGTTACCCTTCAGATAAAGAAGGGAAGAAGCCTAAAGGAC AGTCAAAGAAGCAGCCCAGTGGAACCACAAAAAGGCCAATTTCAGATGATGACTGTCCAAGTGCCTCCAAAGTGTACAAAGCATCAGATT CAGCAGAAGCAATTGAGGCTTTTCAACTAACTCCTCAACAGCAACATCTCATCAGAGAAGATTGTCAAAACCAGAAGCTGTGGGATGAAG TGCTTTCACATCTTGTGGAAGGACCAAATTTTCTGAAAAAATTGGAACAATCTTTTATGTGCGTTTGCTGTCAGGAGCTAGTTTACCAGC CTGTGACAACTGAGTGCTTCCACAATGTCTGTAAAGATTGCCTACAGCGCTCCTTTAAGGCACAGGTTTTCTCCTGCCCTGCTTGCCGGC ATGATCTTGGCCAGAATTACATCATGATTCCCAATGAGATTCTGCAGACTCTACTTGACCTTTTCTTCCCTGGCTACAGCAAAGGACGAT GATCTGCCTGCTTTCACTGTGTTGTTCATGGTGGCTTTTTGGACAATAAAGAATCTAAAATGGGTGGGGAGGGTGGAAGAAATGGTGGAC TGTATCTCTCACGTTCTGAAGCAGCTAATCCTCTTTCCCACATAGCCATCATCTTGTGTGTGTAGTAAGAGGCCCATTTCTCAACTGTCT TTTAAATATCTAAAGGTAGTTCCTGTAACAACTAGTTTTAATGAGTAAAAAGTCAAAGCCTCAGCTCTAGTTGATATCCAAGTTATGATT TATTTTGCAACTACCTCAGGACAGAAAAGATTTATGGGGATTTTAAAAATCATTGAATAACTAGTTAAATGAAATTTTAGCTACACACTG CCTCCCAAATATTAGTTGTGCCTGGTTCTTGTAATTTGATTTTACAGAAAAGGAAATGACACTTGAGATCCTTGGAATGAACACAGCTTC TAAAGTGTGCATATACTTTTTTAACGTCTCTTCTTCCATTACAATGTGTGTTTTGCAAGGACAGGTTCATTTTTTTTAGCCCACTTTGTG AACTCCATTGTGCTTTTTTCTGGTGTTTTATGCAAGTTGACTACTAATGACTAATGAGAACAATAATGAATGCATTGTTGCTGCATTAGT GTAATGTGGTGTGGTTTTGCACTTAAAAGAGGTATTCATATGCTCTAGTTGTAAATGTTCATGAAAATCCACTTCTCTACTAGTCGAACT GCTTTTAGTGTCTCACCAGTGGTTTTACATCTGCAGAGTTTTGAGGGCTGTGCTGACCTTTGAGAGGATTTGAAATTGCTTCATATTGTG >In-frame_ENST00000380667_ENST00000276893_TCGA-DX-AB2E-01A_BNC2_chr9_16870644_-_UHRF2_chr9_6420912_length(amino acids)=775AA_start in transcript=14_stop in transcript=2341 MVQARPLRGDQEAGAALDNQHAEMLENGYTLFDYDVGLNDIIQLLVRPDPDHLPGTSTQIEAKPCSNSPPKVKKAPRVGPSNQPSTSARA RLIDPGFGIYKVNELVDARDVGLGAWFEAHIHSVTRASDGQSRGKTPLKNGSSCKRTNGNIKHKSKENTNKLDSVPSTSNSDCVAADEDV IYHIQYDEYPESGTLEMNVKDLRPRARTILKWNELNVGDVVMVNYNVESPGQRGFWFDAEITTLKTISRTKKELRVKIFLGGSEGTLNDC KIISVDEIFKIERPGAHPLSFADGKFLRRNDPECDLCGGDPEKKCHSCSCRVCGGKHEPNMQLLCDECNVAYHIYCLNPPLDKVPEEEYW YCPSCKTDSSEVVKAGERLKMSKKKAKMPSASTESRRDWGRGMACVGRTRECTIVPSNHYGPIPGIPVGSTWRFRVQVSEAGVHRPHVGG IHGRSNDGAYSLVLAGGFADEVDRGDEFTYTGSGGKNLAGNKRIGAPSADQTLTNMNRALALNCDAPLDDKIGAESRNWRAGKPVRVIRS FKGRKISKYAPEEGNRYDGIYKVVKYWPEISSSHGFLVWRYLLRRDDVEPAPWTSEGIERSRRLCLRLQYPAGYPSDKEGKKPKGQSKKQ PSGTTKRPISDDDCPSASKVYKASDSAEAIEAFQLTPQQQHLIREDCQNQKLWDEVLSHLVEGPNFLKKLEQSFMCVCCQELVYQPVTTE -------------------------------------------------------------- >In-frame_ENST00000380667_ENST00000381373_TCGA-DX-AB2E-01A_BNC2_chr9_16870644_-_UHRF2_chr9_6420912_length(transcript)=662nt_BP=86nt CGGCGGCCGAGGGGCTGGTCCAGGCGCGGCCGCTAAGAGGAGACCAAGAGGCGGGGGCTGCACTTGACAACCAGCATGCCGAGATGTTGG AAAATGGATATACCTTATTTGATTATGATGTTGGACTGAATGATATAATTCAGCTGCTAGTTCGCCCAGACCCTGATCATCTTCCTGGCA CATCTACACAGATTGAGGCTAAACCCTGTTCTAATAGTCCACCTAAAGTAAAGAAAGCTCCGAGGGTAGGACCTTCCAATCAGCCATCTA CATCAGCTCGTGCCCGTCTTATTGATCCTGGCTTTGGAATATATAAGGGTCTGGCTCTGTCACCCAGGCTGTAGTGCAGTGACGTGAACA CGGCTCGCTGTAGCCTTGACCTGCTGGGGTCAAGTGATCTTCCTGCTCGGCCTCCCAAAGTGCTGGGATACAGGCGTGAGCCACCATGCC CGGCTAACTTAGATCTTTGATATCTTGATTAGTTCTTTCTTTACATATTTAATATTTTGCTTTATTTCTGGTAGCTTTGTTTTTGATGCA ATTATTATATATGGTTATCTTCTAAAATAGTAATCTGTTTGCTGATATAGAGAAATGAAATTGATTTATTTGGCTTTTGTAACCAGCAAC >In-frame_ENST00000380667_ENST00000381373_TCGA-DX-AB2E-01A_BNC2_chr9_16870644_-_UHRF2_chr9_6420912_length(amino acids)=109AA_start in transcript=14_stop in transcript=343 MVQARPLRGDQEAGAALDNQHAEMLENGYTLFDYDVGLNDIIQLLVRPDPDHLPGTSTQIEAKPCSNSPPKVKKAPRVGPSNQPSTSARA -------------------------------------------------------------- >In-frame_ENST00000380666_ENST00000276893_TCGA-DX-AB2E-01A_BNC2_chr9_16870644_-_UHRF2_chr9_6420912_length(transcript)=3274nt_BP=143nt GAGGCCCGGAGGAACTCGGAGGGGGAGGGAGAGAAAGGCCGAGACGGAGGGAGCCAGCGGCGGCCGAGGGGCTGGTCCAGGCGCGGCCGC TAAGAGGAGACCAAGAGGCGGGGGCTGCACTTGACAACCAGCATGCCGAGATGTTGGAAAATGGATATACCTTATTTGATTATGATGTTG GACTGAATGATATAATTCAGCTGCTAGTTCGCCCAGACCCTGATCATCTTCCTGGCACATCTACACAGATTGAGGCTAAACCCTGTTCTA ATAGTCCACCTAAAGTAAAGAAAGCTCCGAGGGTAGGACCTTCCAATCAGCCATCTACATCAGCTCGTGCCCGTCTTATTGATCCTGGCT TTGGAATATATAAGGTAAATGAATTGGTGGATGCCAGAGATGTCGGCCTTGGTGCTTGGTTTGAAGCACACATACATAGTGTTACTAGAG CTTCTGATGGACAGTCACGTGGCAAAACTCCACTGAAGAATGGCAGTTCTTGTAAAAGGACTAATGGAAATATAAAGCATAAATCCAAAG AGAACACAAATAAATTGGACAGTGTACCCTCTACGTCTAATTCAGACTGTGTTGCTGCTGATGAAGACGTTATTTACCATATCCAGTATG ATGAATACCCAGAAAGCGGTACTCTAGAAATGAATGTCAAGGATCTTAGACCACGAGCTAGAACCATTTTGAAATGGAATGAACTAAATG TTGGTGATGTGGTAATGGTTAATTATAATGTAGAAAGTCCTGGACAAAGAGGATTCTGGTTTGATGCAGAAATTACCACATTGAAGACAA TCTCAAGGACCAAAAAAGAACTTCGTGTGAAAATTTTCCTGGGGGGTTCTGAAGGAACATTAAATGACTGCAAGATAATATCTGTAGATG AAATCTTCAAGATTGAGAGACCTGGAGCCCATCCCCTTTCATTTGCAGATGGAAAGTTTTTAAGGCGAAATGACCCTGAATGTGACCTGT GTGGTGGAGACCCAGAAAAGAAATGTCATTCTTGCTCCTGTCGTGTATGTGGTGGGAAACATGAACCCAACATGCAGCTTCTGTGTGATG AATGTAATGTGGCTTATCATATTTACTGTCTGAATCCACCTTTGGATAAAGTCCCAGAAGAGGAATACTGGTATTGTCCTTCTTGTAAAA CTGATTCCAGTGAAGTTGTAAAGGCTGGTGAAAGACTCAAGATGAGTAAAAAGAAAGCAAAGATGCCGTCAGCTAGTACTGAAAGCCGAA GAGACTGGGGCAGGGGAATGGCTTGTGTTGGTCGTACGAGAGAATGTACTATTGTCCCTTCTAATCATTATGGACCCATTCCTGGTATTC CTGTTGGATCAACTTGGAGATTTAGAGTTCAGGTGAGCGAAGCAGGTGTTCACAGACCCCATGTTGGTGGAATTCATGGTCGAAGTAATG ATGGGGCTTATTCTCTTGTACTGGCTGGTGGATTTGCGGATGAAGTCGACCGAGGTGATGAGTTCACATACACTGGAAGCGGTGGTAAAA ATCTTGCTGGTAACAAAAGAATTGGTGCACCTTCAGCTGATCAAACATTAACAAACATGAACAGGGCATTGGCCCTAAACTGTGATGCTC CATTGGATGATAAAATTGGAGCAGAGTCTCGGAATTGGAGAGCTGGTAAGCCAGTCAGAGTGATACGCAGTTTTAAAGGGAGGAAGATCA GCAAATATGCTCCTGAAGAAGGCAACAGATATGATGGCATTTATAAGGTGGTGAAATACTGGCCAGAGATTTCATCAAGCCATGGATTCT TGGTTTGGCGCTATCTTTTAAGAAGAGATGATGTTGAACCTGCTCCTTGGACCTCTGAAGGAATAGAACGGTCAAGGAGATTATGTCTAC GTTTACAGTATCCAGCAGGTTACCCTTCAGATAAAGAAGGGAAGAAGCCTAAAGGACAGTCAAAGAAGCAGCCCAGTGGAACCACAAAAA GGCCAATTTCAGATGATGACTGTCCAAGTGCCTCCAAAGTGTACAAAGCATCAGATTCAGCAGAAGCAATTGAGGCTTTTCAACTAACTC CTCAACAGCAACATCTCATCAGAGAAGATTGTCAAAACCAGAAGCTGTGGGATGAAGTGCTTTCACATCTTGTGGAAGGACCAAATTTTC TGAAAAAATTGGAACAATCTTTTATGTGCGTTTGCTGTCAGGAGCTAGTTTACCAGCCTGTGACAACTGAGTGCTTCCACAATGTCTGTA AAGATTGCCTACAGCGCTCCTTTAAGGCACAGGTTTTCTCCTGCCCTGCTTGCCGGCATGATCTTGGCCAGAATTACATCATGATTCCCA ATGAGATTCTGCAGACTCTACTTGACCTTTTCTTCCCTGGCTACAGCAAAGGACGATGATCTGCCTGCTTTCACTGTGTTGTTCATGGTG GCTTTTTGGACAATAAAGAATCTAAAATGGGTGGGGAGGGTGGAAGAAATGGTGGACTGTATCTCTCACGTTCTGAAGCAGCTAATCCTC TTTCCCACATAGCCATCATCTTGTGTGTGTAGTAAGAGGCCCATTTCTCAACTGTCTTTTAAATATCTAAAGGTAGTTCCTGTAACAACT AGTTTTAATGAGTAAAAAGTCAAAGCCTCAGCTCTAGTTGATATCCAAGTTATGATTTATTTTGCAACTACCTCAGGACAGAAAAGATTT ATGGGGATTTTAAAAATCATTGAATAACTAGTTAAATGAAATTTTAGCTACACACTGCCTCCCAAATATTAGTTGTGCCTGGTTCTTGTA ATTTGATTTTACAGAAAAGGAAATGACACTTGAGATCCTTGGAATGAACACAGCTTCTAAAGTGTGCATATACTTTTTTAACGTCTCTTC TTCCATTACAATGTGTGTTTTGCAAGGACAGGTTCATTTTTTTTAGCCCACTTTGTGAACTCCATTGTGCTTTTTTCTGGTGTTTTATGC AAGTTGACTACTAATGACTAATGAGAACAATAATGAATGCATTGTTGCTGCATTAGTGTAATGTGGTGTGGTTTTGCACTTAAAAGAGGT ATTCATATGCTCTAGTTGTAAATGTTCATGAAAATCCACTTCTCTACTAGTCGAACTGCTTTTAGTGTCTCACCAGTGGTTTTACATCTG CAGAGTTTTGAGGGCTGTGCTGACCTTTGAGAGGATTTGAAATTGCTTCATATTGTGATCCTAAATTTTATATTCACTATATTCCCTAAA >In-frame_ENST00000380666_ENST00000276893_TCGA-DX-AB2E-01A_BNC2_chr9_16870644_-_UHRF2_chr9_6420912_length(amino acids)=775AA_start in transcript=71_stop in transcript=2398 MVQARPLRGDQEAGAALDNQHAEMLENGYTLFDYDVGLNDIIQLLVRPDPDHLPGTSTQIEAKPCSNSPPKVKKAPRVGPSNQPSTSARA RLIDPGFGIYKVNELVDARDVGLGAWFEAHIHSVTRASDGQSRGKTPLKNGSSCKRTNGNIKHKSKENTNKLDSVPSTSNSDCVAADEDV IYHIQYDEYPESGTLEMNVKDLRPRARTILKWNELNVGDVVMVNYNVESPGQRGFWFDAEITTLKTISRTKKELRVKIFLGGSEGTLNDC KIISVDEIFKIERPGAHPLSFADGKFLRRNDPECDLCGGDPEKKCHSCSCRVCGGKHEPNMQLLCDECNVAYHIYCLNPPLDKVPEEEYW YCPSCKTDSSEVVKAGERLKMSKKKAKMPSASTESRRDWGRGMACVGRTRECTIVPSNHYGPIPGIPVGSTWRFRVQVSEAGVHRPHVGG IHGRSNDGAYSLVLAGGFADEVDRGDEFTYTGSGGKNLAGNKRIGAPSADQTLTNMNRALALNCDAPLDDKIGAESRNWRAGKPVRVIRS FKGRKISKYAPEEGNRYDGIYKVVKYWPEISSSHGFLVWRYLLRRDDVEPAPWTSEGIERSRRLCLRLQYPAGYPSDKEGKKPKGQSKKQ PSGTTKRPISDDDCPSASKVYKASDSAEAIEAFQLTPQQQHLIREDCQNQKLWDEVLSHLVEGPNFLKKLEQSFMCVCCQELVYQPVTTE -------------------------------------------------------------- >In-frame_ENST00000380666_ENST00000381373_TCGA-DX-AB2E-01A_BNC2_chr9_16870644_-_UHRF2_chr9_6420912_length(transcript)=719nt_BP=143nt GAGGCCCGGAGGAACTCGGAGGGGGAGGGAGAGAAAGGCCGAGACGGAGGGAGCCAGCGGCGGCCGAGGGGCTGGTCCAGGCGCGGCCGC TAAGAGGAGACCAAGAGGCGGGGGCTGCACTTGACAACCAGCATGCCGAGATGTTGGAAAATGGATATACCTTATTTGATTATGATGTTG GACTGAATGATATAATTCAGCTGCTAGTTCGCCCAGACCCTGATCATCTTCCTGGCACATCTACACAGATTGAGGCTAAACCCTGTTCTA ATAGTCCACCTAAAGTAAAGAAAGCTCCGAGGGTAGGACCTTCCAATCAGCCATCTACATCAGCTCGTGCCCGTCTTATTGATCCTGGCT TTGGAATATATAAGGGTCTGGCTCTGTCACCCAGGCTGTAGTGCAGTGACGTGAACACGGCTCGCTGTAGCCTTGACCTGCTGGGGTCAA GTGATCTTCCTGCTCGGCCTCCCAAAGTGCTGGGATACAGGCGTGAGCCACCATGCCCGGCTAACTTAGATCTTTGATATCTTGATTAGT TCTTTCTTTACATATTTAATATTTTGCTTTATTTCTGGTAGCTTTGTTTTTGATGCAATTATTATATATGGTTATCTTCTAAAATAGTAA >In-frame_ENST00000380666_ENST00000381373_TCGA-DX-AB2E-01A_BNC2_chr9_16870644_-_UHRF2_chr9_6420912_length(amino acids)=109AA_start in transcript=71_stop in transcript=400 MVQARPLRGDQEAGAALDNQHAEMLENGYTLFDYDVGLNDIIQLLVRPDPDHLPGTSTQIEAKPCSNSPPKVKKAPRVGPSNQPSTSARA -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for BNC2-UHRF2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
Tgene | UHRF2 | chr9:16870644 | chr9:6420912 | ENST00000276893 | 0 | 16 | 194_288 | 51.0 | 803.0 | PCNP |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for BNC2-UHRF2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for BNC2-UHRF2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | BNC2 | C0008925 | Cleft Palate | 1 | CTD_human |
Hgene | BNC2 | C0238506 | Congenital posterior urethral valves | 1 | GENOMICS_ENGLAND;ORPHANET |
Hgene | BNC2 | C0376634 | Craniofacial Abnormalities | 1 | CTD_human |
Hgene | BNC2 | C0919267 | ovarian neoplasm | 1 | CTD_human |
Hgene | BNC2 | C1140680 | Malignant neoplasm of ovary | 1 | CTD_human |
Hgene | BNC2 | C1837218 | Cleft palate, isolated | 1 | CTD_human |